$62.36
5.61% day before yesterday
Nasdaq, Jan 02, 10:10 pm CET
Why the stock moved Why the stock moved Beta
ISIN
US88023B1035
Symbol
TEM

Tempus AI Stock price

$62.36
-11.61 15.70% 1M
+3.18 5.37% 6M
+3.31 5.61% YTD
+28.11 82.07% 1Y
+25.36 68.54% 3Y
+25.36 68.54% 5Y
+25.36 68.54% 10Y
+25.36 68.54% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
+3.31 5.61%

New AI Insights on Tempus AI Insights AI Insights on Tempus AI

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$11.1b
Enterprise Value
$11.6b
Net debt
$486.0m
Cash
$759.6m
Shares outstanding
177.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
10.0 | 8.7
EV/Sales
10.5 | 9.1
EV/FCF
negative
P/B
21.9
Financial Health
Equity Ratio
6.1%
Return on Equity
-1,324.7%
ROCE
-12.5%
ROIC
-14.7%
Debt/Equity
2.5
Financials (TTM | estimate)
Revenue
$1.1b | $1.3b
EBITDA
$-226.7m | $506.2k
EBIT
$-242.2m | $-52.1m
Net Income
$-203.9m | $-110.7m
Free Cash Flow
$-249.4m
Growth (TTM | estimate)
Revenue
72.6% | 84.2%
EBITDA
66.7% | 100.1%
EBIT
65.0% | 92.4%
Net Income
74.5% | 85.2%
Free Cash Flow
9.6%
Margin (TTM | estimate)
Gross
61.7%
EBITDA
-20.5% | 0.0%
EBIT
-21.9%
Net
-18.5% | -8.7%
Free Cash Flow
-22.6%
More
EPS
$-1.2
FCF per Share
$-1.4
Short interest
13.7%
Employees
-
Rev per Employee
-
Show more

Is Tempus AI a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Tempus AI Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Tempus AI forecast:

11x Buy
58%
8x Hold
42%

Analyst Opinions

19 Analysts have issued a Tempus AI forecast:

Buy
58%
Hold
42%

Financial data from Tempus AI

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,105 1,105
73% 73%
100%
- Direct Costs 423 423
41% 41%
38%
682 682
100% 100%
62%
- Selling and Administrative Expenses 757 757
14% 14%
68%
- Research and Development Expense 152 152
6% 6%
14%
-227 -227
67% 67%
-21%
- Depreciation and Amortization 15 15
35% 35%
1%
EBIT (Operating Income) EBIT -242 -242
65% 65%
-22%
Net Profit -204 -204
75% 75%
-18%

In millions USD.

Don't miss a Thing! We will send you all news about Tempus AI directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tempus AI Stock News

Positive
Seeking Alpha
16 days ago
Tempus AI (NASDAQ:TEM) is rated a strong buy for risk-tolerant investors, leveraging its vast proprietary healthcare data to drive precision medicine via AI and ML. TEM delivered 85% YoY revenue growth in Q3 2025, with organic oncology and hereditary testing volumes up 27% and 37%, and achieved positive adjusted EBITDA. The company's data moat, expanding test portfolio, and software ambitions p...
Positive
Seeking Alpha
18 days ago
Tempus AI remains a Buy after a market-driven correction, with operational performance and partnerships strengthening the long-term thesis. TEM's organic revenue grew 28% y/y, gross margins improved 450bps to 63%, and liquidity increased to $760M, supporting continued investment and debt service. Management targets sustainable 25% annual genomics growth through 2028, with high-margin Data & Ins...
Positive
The Motley Fool
25 days ago
Cathie Wood bought shares of Baidu, WeRide, and Tempus AI on Monday. Baidu has rallied on its rising AI chips business in China, but it's still textbook cheap.
More Tempus AI News

Company Profile

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Head office United States
CEO Eric Lefkofsky
Website investors.tempus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today